Clinical Trial Detail

NCT ID NCT03642132
Title Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Pfizer
Indications

peritoneum cancer

fallopian tube cancer

ovary epithelial cancer

Therapies

Bevacizumab + Carboplatin + Paclitaxel

Carboplatin + Paclitaxel + Talazoparib

Avelumab + Carboplatin + Paclitaxel + Talazoparib

Age Groups: senior adult

No variant requirements are available.